Navigation Links
ITRA Global Elects 2014 Board of Directors and Officers
Date:12/20/2013

Chicago (PRWEB) December 20, 2013

ITRA Global announced today that Mylinda J. Vick, CCIM, principal of Cherry & Associates / ITRA Global Nashville, was re-elected chairman of the board of directors for 2014. Through Ms. Vick’s dynamic leadership in 2013, ITRA Global remains one of the largest International organizations devoted to representing users of corporate space.

“I am thrilled to serve in the role of Chairman of the Board for another term”, says Ms. Vick. “ITRA Global remains one of the few organizations that truly advocates for corporate tenants and buyers of office, industrial and retail space. As I reflect on the accomplishments of our organization during the past year, I thank my fellow board members and committee members for their dedication and commitment as we continue to expand our global offices to effectively serve the needs of our local and multi-market corporate clients.”

Ms. Vick is a 19-year veteran in corporate real estate. As a principal of Cherry & Associates / ITRA Global, established in 1994 as an exclusive tenant/buyer representation firm, Ms. Vick has completed over $300M in transactional volume. She has been recognized repeatedly by CoStar Group, Inc. as a “Top Power Broker” and has been named one of the “Top Brokers” selected by the Nashville Business Journal. Her work with corporate clients includes Bridgestone, Viacom Corporation, Baker Donelson Bearman Caldwell & Berkowitz, Mars Petcare, Inc., Thomas Nelson Publishing, Cisco Systems and Verizon, to name a few.

Serving with Ms. Vick on the ITRA Global 2014 leadership team are: Carrie Holstead of Carrie S. Holstead Real Estate Consultants, Inc. / ITRA Global Pittsburgh, as Vice Chairman; Martin Levy of The Levy Group / lTRA Global London, as Secretary; Stuart Holcombe, CCIM of Corporate Real Estate Advisors / ITRA Global Atlanta, as Treasurer; and Chris Atwater, CCIM, MAI of Michigan Commercial Space Advisors / ITRA Global, as director. Serving as Chairman Emeriti are Debra Stracke Anderson, CCIM, SIOR, of Sloan Street Advisors / ITRA Global Washington D.C., and Ronald R. Pollina, PhD, of Pollina Corporate Real Estate / ITRA Global Chicago.

With coverage in major markets, ITRA Global is the one of the largest real estate organizations dedicated to representing tenants and buyers of office, industrial and retail space, offering a unique approach to Corporate Real Estate Services. ITRA offices are comprised of principal-level professionals offering lease and renewal negotiations, acquisitions and dispositions, together with highly specialized advisory services, such as state and local incentive negotiations, lease audits, lease management, location analysis, project management, strategic consulting, space planning and more.

For more information about ITRA Global, please call Beth Wade, ITRA Global Executive Director, at +1.706.654.3201, or visit the ITRA Global website.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11441101.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market
2. Novogen Announces Establishment of Global Collaboration to Drive The Development of Drugs to Treat Brain Cancer
3. CNTS Awarded $40 Million Contract Supporting U.S. Military Through Global Public Health
4. Global Cell Culture Market Report 2013-2018
5. Global Bulk Molding Compounds Market and China LOW-E Glass Analysis in New Research Added to DeepResearchReports.com
6. Global Next Generation Sequencing (NGS) Market Report 2013-2017
7. Biomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020 - Allied Market Research
8. Global Geosynthetics Market 2012-2016
9. ITRA Global’s Detroit Affiliate Awarded Contract to Manage Real Estate for Michigan’s Western and Southeastern Regions
10. Increasing Focus on Customization of Healthcare Drives the Market for Personalized Medicine, According to a Soon to be Released Report by Global Industry Analysts, Inc.
11. Growing Interest in Regenerative Medicine to Drive the Mesenchymal Stem Cells Market, According to a Soon to Be Released Report by Global Industry Analysts, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI Express, announced ... FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)... Fla. , Dec. 8, 2016  HedgePath ... company that discovers, develops and plans to commercialize ... its shares of common stock were approved for ... will begin trading on the OTCQX, effective today, ... qualify for the OTCQX market, companies must meet ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
Breaking Biology Technology:
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint ... ... Multi-Biometric supplier: The company's Fingerprint Identification System is part of an efficient ...
(Date:11/21/2016)... VILNIUS, Lithuania , Nov. 21, 2016 /PRNewswire/ ... identification and object recognition technologies, today announced that ... for smart cards was submitted for the ... and successfully passed all the mandatory steps of ... III evaluation is a continuing test of fingerprint ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
Breaking Biology News(10 mins):